Abstract:Background: Race and ethnicity (R/E) information is crucial for understanding health disparities and the efficacy/effectiveness of treatments across different patient groups. However, these data are often missing or inaccurate in EHR. Literature suggests that surveys can improve upon these gaps in EHR R/E data. FDA recently issued guidance on collecting and reporting R/E data using standardized terminology, which should be applied to demographic data in new clinical trials and studies. N-Power Medicine (NPM) developed a concise survey, incorporating FDA's R/E recommendations, to collect SDoH data as part of its registry (Kaleido) enhanced oncology network platform for quality data collection. Here, we report the initial R/E findings from this survey. Methods: Patients participating in the Kaleido Registry at 2 community oncology practices across different US regions completed the survey during their clinic visits with assistance from NPM onsite staff. The survey allowed multiple race selections to include mixed races and a free-text option for "Other". R/E data from the same patients were also extracted from EHRs. Completeness was reported as the percentage of informative answers: any race, other, and chose not to disclose. "Unknown" and "Not available" were missing data. Results: Between November 11, 2023 and April 30, 2024, 1109 patients completed the questionnaire with over 99% response rate. Both sites contributed equally and had similar patient demographics: about 61% female and 79% aged 60 or above. The large majority of patients had breast cancer followed by lung and colorectal cancers. Survey completeness was 96.7% for race and 99.6% for ethnicity, as compared with EHR completeness of 78.6% for race and 91.1% for ethnicity. 21% of EHR data for race was coded as "Unknown and Not Available. About 20% of the survey respondents were Hispanic or Latino. Both sites' EHR data included expected R/E categories except for one site having 21 additional unique race entries. The majority of survey participants were White (W, 75.7%) followed by Asian (A, 3.6%), American Indian or Alaska Native (AI/AN, 3.2%), Black or African American (B/AA, 2.4%), Native Hawaiian or Pacific Islander (NH/PI, 1.0%) and multiple-selection (2.9%; Other and W (8), AI/AN (3), A (2); W and AI/AN (10), A (7); A and AI/AN (1), W and B (1)). 11% of responses were Other, which included various races (15% European/Caucasian), nationalities, ethnicities (49% Hispanic) and religions, hence, could be further disambiguated. We will report details regarding the survey respondent's other SDoH. Conclusions: We successfully implemented a standardized questionnaire, incorporating FDA R/E collection recommendations, at two community oncology sites. The results demonstrate that the NPM R/E questionnaire has higher completeness compared to EHR data, allowing better assessment of the impact of R/E on clinical trial enrollment, genomic testing utilization, treatment patterns, and outcomes. This improvement is vital for understanding and addressing health disparities in oncology care. Citation Format: Michael Zachary Koontz, Ayse Tezcan, Julie Latham, Phyllis Ortiz, Joseph Nathaniel Paulson, Annette Campbell Fontaine. Improving Race and Ethnicity Data Completeness Using a Concise Survey Designed to Collect Social Determinants of Health (SDoH) Data: Results from Two Community Oncology Practices [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl) nr B051.

Integrating social drivers of health screening into ambulatory cancer care.

Evaluation of a social determinants of health screening questionnaire and workflow pilot within an adult ambulatory clinic

Integrating Social Needs Screening and Resource Referral Into Standard Ambulatory Oncology Care: A Quality Improvement Project

Abstract 815: Leveraging clinical workflow for rapid integration of social needs assessment in a urologic oncology clinical practice

Screening for social determinants of health among patients with advanced and metastatic cancer undergoing comprehensive genomic profiling in underserved communities.

Assessing social determinants of health and optimizing resource support for patients with metastatic breast cancer: Results from the LIFT-UP study.

Improving Screening for Social Determinants of Health in an Outpatient Complex Care Clinic

Examining disparities in large-scale patient-reported data capture using digital tools among cancer patients at clinical intake

Representativeness of race, ethnicity and social determinants of health in patients with advanced non-small cell lung cancer via linkage of real-world electronic health records, administrative claims, and consumer financial data.

System-wide depression screening implementation in ambulatory oncology care: Key strategies and early implementation outcomes.

Assessing Patient Perspectives and the Health Equity of a Digital Cancer Symptom Remote Monitoring and Management System

Abstract B051: Improving Race and Ethnicity Data Completeness Using a Concise Survey Designed to Collect Social Determinants of Health (SDoH) Data: Results from Two Community Oncology Practices

Impact of a care delivery intervention for patients with socioeconomic disadvantages, in their preferred language of English or Spanish.

Implementation of Systematic Financial Screening in an Outpatient Breast Oncology Setting

Social determinants of health and US cancer screening interventions: A systematic review

Abstract C131: Understanding the impact of social risk factors on cancer care delivery: A scoping review

Identification of complex co-occurring symptom burden in persons with cancer through multisite implementation of health-related social needs assessment in community oncology settings.

Rapid survey assessment: Barriers and facilitators to mammogram completion in English and Spanish-speaking patients in a federally qualified health center (FQHC) setting.

A multi-level system quality improvement project to reduce disparities in lung cancer screening: The Sylvester Lung Screening Project.

Abstract PO3-09-08: Using Social Determinants of Health to Improve Surgical Delays for Breast Cancer Patients at Rush University Cancer Center

Implementing a nurse-led screening clinic for symptom distress with community-based referral for cancer survivors: A feasibility study